Microfluidics is an emerging technology with growing acceptability in healthcare applications. The key driver for the microfluidics market is the ‐great (or rising) demand in point-of-care (POC) and in-vitro diagnostics. For example, according to World Health Organization (WHO), 95 million people received HIV testing in low and middle-income countries in 2010.